Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
Status:
Recruiting
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
This is a prospective, single arm, phase II clinical study to evaluate the efficacy and
safety of Zimberelimab combined with albumin-bound paclitaxel and cisplatin as neoadjuvant
therapy for locally advanced cervical cancer.